Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

SmithKline Beecham's new Havrix formulation receives Canadian approval

July 19, 1996

Janssen describes agent for decreased intestinal motility

July 19, 1996

CJ-12954: Pfizer's anti-Helicobacter pylori compound

July 19, 1996

Clinical trials begin for chronic hepatitis C agent, Alferon N Injection

July 12, 1996

Lamivudine for treatment of hepatitis B covered under U.S. patent

July 12, 1996

Otsuka peptide IL-1 production inhibitors in pipeline

July 12, 1996

Novopharm favored in patent infringement suit with Glaxo Wellcome

July 12, 1996

Good phase I results reported for Campylobacter vaccine

July 5, 1996

Ketotifen shown effective in NSAID-induced ulcer model

July 5, 1996

Nadolol/isosorbide monohydrate combination prevents rebleeding

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...